To explore the expression and function of the membrane-associated or type I trans glutaminase (TGasel) in human epidermis, we have made a new antihuman TGase 1 antibody in goats elicited against a purified active recombinant protein expressed in bacteria. By use of Western blotting and immunoprecipitation methods, the antibody reacted with high specificity with only the TGase 1 activity of the epidermis and in cultured keratinocytes. By indirect immunofluorescence, the antibody decorated the entire epidermis, including the basal layer, with some potentiation of the granular layer. However, these staining properties are quite different from those of a widely used, commercially available TGasel monoclonal antibody (termed B.Cl), which decorates ne of the striking events during the process of terminal differentiation in stratified squamous epithelia such as the epidermis is the formation of a 15-nm-thick layer of protein on the inner surface of the cell periphery, termed the cornified cell envelope (CE) [1-3]. The CE is now known to be assembled by the accumulation of several distinct proteins, including involucrin [4, 5] , cystatin A (previously known as keratolinin) [6] [7] [8] , several small proline-rich proteins (SPRs) [7,9 -11 ], trichohyalin [12], loricrin [13][14] [15] [16] , and possibly filaggrin [17, 18] and keratin intermediate filaments [18, 19]. § Although the temporal order of deposition and even the abundance of these structural proteins have not yet been established unambiguously (but see [1] [2] [3] 18] ), it is clear that they are cross-linked together by the formation of NE-(y-glutamyl) lysine isodipeptide bonds catalyzed by the action of at least two different transglutaminases (TGases) expressed in the epidermis [1] [2] [3]14, 20] . TGase1 is membrane-associated and is expressed in abundance in cultured epithelial cells and in intact epidermis [21, 22]. By use of in situ hybridization with TGase1-specific antisense RNA probes, TGase1 mRNA is detectable in the spinous
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Abbreviations: CE, cornified cell envelope; PTH, phenylthiolhydantoin; SPR, small proline-rich (class of proteins); TGase, transglutarninase; TGase1 (etc), suggested new nomenclature for transglutaminases (see [29] ). § Ming ME, Daryanami HA, Roberts JE, Haimowitz JE, Kvedar JC: Participation of mouse keratin 10 in the crosslinking of the cornified cell envelope ofkeratinocytes (abstr).] Invest DermatoI100: 578, 1993. the granular layers of the epidermis. By Western blotting, it identifies the TGase 1 protein band only weakly, but recognizes strongly a group of bands of 15-20 kDa, two of which by amino acid analysis and amino acid sequencing are the small proline-rich (SPR) 1 and SPR2 proteins, also expressed in epidermal and epithelial tissues. Together with a series of blocking experiments with TGase 1 proteins and synthetic peptides, these data reveal that the major epitope of the B.Cl antibody most likely resides on the amino-terminus of these two SPR proteins rather than on TGase 1. Further studies will now be necessary to determine the role(s) of TGasel during the different stages of development and differentiation in the epidermis. ] Invest Dermatol 104: [211] [212] [213] [214] [215] [216] [217] 1995 and granular layers of the epidermis [23,24]. However, by indirect immunofluorescence using a commercially available antibody termed B. C 1, TGase 1 protein expression appears to be confined to the granular layer [21, 22] . Accordingly, it has been proposed that TGase1 mRNA is controlled post-transcriptionally in the epidermis [23] [24] [25] . On the other hand, TGase3 is a soluble pro-enzyme, requiring proteolytic activation by cleavage at a unique flexible hinge site about two thirds of the way along the protein [26, 27] . ~ Although in situ hybridization experiments have not yet been reported, protein expression appears to occur only in the granular layer of intact epidermis, and it is not expressed to a significant extent in cultured epithelial cells [26, 27] .1f The precise functions or substrate specificities, if any, of either of these enzymes remain unknown. Nevertheless, based on localization of the various substrates and enzymes by the use of antibodies, the notion has arisen that the more soluble substrates, involucrin and cystatin A, are deposited first and are perhaps cross-linked by TGase 1 to form a "scaffold" [5, 18, 28] , to which the less soluble proteins are added later and perhaps cross-linked by TGase3 [1-3,18].
In an attempt to understand these complex processes and to test these hypotheses, we have begun to characterize the human TGase1 enzyme system [29] [30] [31] . Unfortunately, the protein is very unstable and is difficult to isolate or purify in quantity for direct biochemical experiments [22] . For this reason, we have used recombinant DNA and deletion cloning experiments. We have prepared the full-length and a series of truncated forms of TGase 1 
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and have expressed them in bacteria [31] . In this way, we identified the smallest possible form of the enzyme, having the first 109 and last 241 amino acid residues deleted, which still retains about 50% of the activity of the full-length TGase 1 enzyme. We have now produced anew, highly specific polyclonal antibody elicited against this severely truncated but active form and describe its properties here. By indirect immunofluorescence, this new antibody indicates that the TGasel enzyme is expressed throughout the epidermis, with some potentiation in the granular layer, commensurate with the expression of its mRNA. This finding contrasts surprisingly with earlier reports with the B.el antibody.
MATERIALS AND METHODS
Preparation of TGases Using our full-length cDNA clone encoding human TGase1 (major variant) [29, 30] , we have prepared by polymerase chain reaction methods a series of 21 deletion forms, as well as the full-length TGase1, and subcloned them into the pET11a bacterial expression vector system (Novagen, Madison, WI) using the manufacturer's protocols [31] . These were expressed in the bacteria and purified to electrophoretic purity, and their properties and TGase activities were deternllned [31] . A deletion form (construct 20) having the first 109 and the last 241 amino acids removed was found to be the smallest form that still retained about 50% of the enzyme activity of the full-length (92 kDa) protein [30] . Guinea pig epidermal TGase3 and guinea pig liver TGase2 were prepared exactly as described previously [26, 32] .
Preparation of TGase t Antibody The purified construct-20 recombinant TGasel was used to produce a polyclonal antibody in a goat. Emulsions were prepared containing 0.25 rnl of the synthetic copolymer adjuvant (Titermax Corporation, Norcross, GA) with 0.25 rnl of protein (0.4 mg/ml in phosphate-buffered saline [PBS]), and 50 JLI containing 10 JLg of antigen was injected subdermally into the goat at 10 different sites on days 1 and 14. The animal was boosted at 38 d by intramuscular injection of 1 00 J.1-g at two sites. The highest antibody titer was attained at about 2 months, at which time serum was collected. The antibody was prepared by affinity purification using the recombinant TGasel antigen conjugated to TSK matrix (Reacti-Gel, HW-65F, Pierce, Rockford, IL). The antibody was stored in 0.2% bovine serum albumin solution to retain antibody activity .
Indirect Immunofluorescence Normal adult human trunk skin was frozen immediately and cut into sections 6 J.1-m thick. Procedures for indirect immunofluorescence were followed as before [16, 33, 34] with our new TGasel antibody, the commercially available B.Cl mouse monoclonal antibody (used undiluted as per manufacturer's recommendation, Biomedical Technologies Inc., Stoughton, MA) [21] , or the loricrin carboxylterminal peptide antibody SAF-I02 prepared in goats [14] . The secondary antibodies used were rhodamine-conjugated sheep anti-mouse IgG (Cappel Organon Teknika Corp ., Durham, NC) or fluorescein-conjugated rabbit anti-goat IgG (Cappel). Sections were fixed with acetone for 10 min at -20°C, rinsed with PBS, and treated with 2% gelatin for 10 min. Sections then were incubated at 23°C with primary antibody for 30 min, rinsed, incubated with secondary antibody (1:300 dilution) for 30 min, rinsed, and mounted with 90% glycerol. Sections were observed with a BH2-RFC photomicroscope (Olympus) equipped with an epifluorescence illumination and phase-contrast device. Where necessary, double exposures with both antibodies were used . Antibody-blocking experiments were performed with either the full-length or truncated expressed forms of recombinant TGase 1. TGasel proteins were dissolved in PBS (200 J.1-g/ml) and mixed with 3 vol. of diluted TGasel or undiluted B.CI antibodies (to give a final TGasel concentration of 50 J.1-g/rnl). After incubation for 1 h at 23°C, the reaction was centrifuged at 14,000 X g for 2 min to remove the conjugate, and the supernatant was used as the primary antibody. Similarly, a series of synthetic peptides (see below) was used to block the action of our new TGasel or B.Cl antibodies. A 10-mg/ml solution of peptide dissolved in PBS was mixed with 9 vol. of diluted TGasel or B.Cl antibody for 1 h at 23°C (to give a final peptide concentration of 1 mg/ml) and then centrifuged at 14,000 X g for 2 min to remove the conjugate; the supernatant was used as the primary antibody.
General Immunologic Procedures Western blots were performed exactly as described previously [26] , using the new goat anti-human TGasel antibody described here at 1 :200 dilution, the previously described goat anti-rabbit TGase2 at a 1:100 dilution [32] , and a rabbit anti-guinea pig THE JOURNAL OF INVESTIGATIVE DERMATOLOGY TGase3 antibody at a dilution of 1 :300. ~ Both of the latter specificall) cross-react with the respective human proteins.
Immunoprecipitation reactions were performed as follows. These thre{ antibodies were biotinylated using standard procedures (Pierce). The thre{ purified TGases, either singly or in combination, were dissolved in PB~ solution containing the protease inhibitors leupeptin (5 J.1-g/rnl), aprotinir (10 J.1-g/ml), calpain inhibitor (8 JLg/ml), benzamidine (1 mM), anc phenylmethylsulfonyl fluoride (1 mM), and incubated with serial dilutionf of the biotinylated TGase antibodies for 1 h at 4°C. The immunopure immobilized avidin, cross-linked to 6% beaded agarose (Pierce), was then added to precipitate the biotinylated TGase antibodies. Mter centrifugation, the supernatant was assayed for TGase activity.
Keratinocyte Protein Extracts Normal human foreskin epidermal keratinocytes (Clonetics, CA) were grown to confluency in KGM medium in 1.2 mM CaCl 2 as per the manufacturer's protocol. HaCaT cells, a spontaneous immortalized human epidermal keratinocyte cell line [35] , were grown to confluency in 1.8 mM CaCl 2 in Dulbecco's modification of Eagle's medium containing 10% fetal bovine serum. In both cases, the cells were harvested and sonicated in 0.1 M Tris-acetate, 0.15 M NaCI, and 1 mM ethylenediamine tetraacetic acid (EDT A) containing the cocktail of protease inhibitors described above. The cytosolic fraction and the membrane fractions were separated by centrifugation at 10,000 X g for 30 min, and the latter was washed by sonication three times .
Preparation of an Affinity Column With the B.Ct Antibody The IgG protein of the B.Cl antibody was purified by protein G (Pierce) column chromatography [36] . The eluted IgG was concentrated with YM-I0 membranes and dialyzed against 50 mM borate buffer, pH 8.2, to remove primary amines such as Tris and glycine. The antibody solution was then mixed with immobilized protein G-agarose gel by gentle inversion for 30 min at 23°C. After nonbound proteins were washed out with buffer, the complex of IgG and immobilized protein G was suspended by gentle inversion with dimethyl pimelimidate (6.6 mg/ml) (Pierce) for 1 h at 23°C to catalyze the covalent coupling by way of the imido ester cross-linker between protein G and the IgG Fc region . The remaining active sites of the cross-linker were blocked with 0.1 M ethanolamine-HCI buffer, pH 8.2.
Purification of the B.Ct Reacting Antigens From HaCaT Keratinocytes The washed membrane fraction pellet from HaCaT keratinocytes was dissolved in the extraction buffer containing the nonionic detergent octyl-l3-glucopyranoside (1 %) to dissolve the membranes. The solubilized material was collected by centrifugation at 10,000 X g and then incubated with the immobilized B.Cl antibody overnight at 4°C. Finally, the bound proteins were eluted with 50 mM glycine-HCI buffer, pH 2.8, neutralized, and concentrated with Centricon 3 membranes (Amicon).
Amino Acid Analysis and Sequencing The two bands I and II immunoprecipitated by the B.Cl antibody as described above were resolved on a 16% polyacrylamide gel run in tricine buffers and transferred to polyvinylidenedifluoride membranes . The two bands were excised, and a portion was hydrolyzed directly in 5.7 N HCl at 11 O°C for 22 h and then analyzed on a Beckman 6300 analyzer. A second portion corresponding to about 5 pmol of protein was hydrolyzed in 1 N HCI at 110°C for 1 h to remove the probable N-acetyl blocking group on the amino terminus of the proteins, and dried. The samples then were applied to the inert support filter of a Beckman LF3500 gas phase amino acid sequencer and run for 10 Edman degradation cycles . The phenylthiolhydantoin (PTH)-derivatized amino acids at each cycle were resolved and quantitated by high performance liquid chromatography. The PTH derivative of cysteine is unstable and cannot be ascertained directly, but is inferred from the appearance of PTH-dehydroalanine.
Synthetic Peptides The following were synthesized, then purified by high performance liquid chromatography, and the compositions and concentrations were determined accurately by amino acid analysis [37] . The sequences were based on available published sequence information: 
RESULTS AND DISCUSSION
Specificity and Properties of aNew TGase 1 Antibody There are at least three distinct TGase activities in human epidermis [1-3,25]: the membrane-associated or TGase1 enzyme (approximately 92 kDa), the ubiquitous soluble or tissue TGase2 enzyme (approximately 80 kDa), and proenzyme TGase3 (approximately 77 kDa). Our laboratory has undertaken a major study to understand the role of each of these enzymes during terminal differentiation in the epidermis. Although th~ human TGase2 and guinea pig TGase3 enzymes can be isolated with ease from such tissues as liver and skin, respectively, we have been able to produce significant amounts of human TGase 1 enzyme only after expression of our full-length cDNA clones in bacteria [31] . Polyclonal antibodies for TGase2 [32] , TGase3,~ and a monoclonal antibody for TGase1 (B.C1 [21] ) are available. Whereas the former two are precipitating antibodies, the commercially available form of the latter in our hands works very poorly both on Western blots and in immunoprecipitation reactions. Accordingly, we prepared a new polyclonal antibody in a goat to human TGase 1, elicited against a truncated expressed form. By use of an antibody-precipitation titration assay, we found that our new TGase1 antibody precipitated active full-length (Fig 1) or the various truncated TGase1 enzymes [31] , so that at about a 1:300 dilution, more than 50% of the TGase 1 activity could be precipitated from solution, and virtually all activity was precipitated at a 1:50 dilution. On the other hand, the antibody did not precipitate either the TGase2 or TGase3 enzyme in an identical assay, thus indicating a high degree of specificity (Fig 1) . Conversely, the guinea pig TGase3 antibody precipitated only the TGase3 activity, and not the expressed purified TGase1 enzyme~ (data not shown). Under the same experimental conditions, the B.Cl antibody did not precipitate any of the recombinant TGase1 proteins. Furthermore, by Western blotting, the new antibody was highly specific for only the TGase1 protein band (Fig lb, lane 1) . Similar experiments have shown that this antibody cross-reacts with all of our expressed truncated recombinant forms ofTGase1 [31] . This means that its epitope(s) is located in the central core of and not the extreme ends of the enzyme, or on post-translational modifications of it. Thus, this antibody will be useful for a wide range of biochemical and immunologic procedures.
Similarly, our new TGase 1 antibody recognized a band corresponding to the full-length TGase 1 enzyme in the total proteins of cultured normal human epidermal keratinocytes (Fig 2A, lane 2) or of HaC aT cell line keratinocytes ( Fig 2B, lane 2) . In contrast, under these conditions, several different batches of the commercially available B.C1 antibody detected a band at the region of native enzyme only very weakly (Fig 2A,B, lanes 3) . However, when we made a Western blot of a 4%-to 20%-gradient polyacrylamide gel from the same HaCaT keratinocyte extract, the B.C1 antibody >-... Fig 2C, lane 3) . Other investigators have not reported use of high-percentage polyacrylamide gels in their Western blotting experiments and therefore may have missed the fmding of these additional major precipitated protein bands. TGasel is Expressed Throughout Human Epidermis: Comparison to the B.Cl Antibody Figure 3 shows a series of sections of normal adult human skin examined using indirect immunofluorescence. Our new polyclonal TGase 1 antibody stained the entire epidermis ( Fig 3A,D) , with some potentiation in the granular layers. The basal layer also was stained, although at a reduced extent. In contrast, the commercially available B.C1 monoclonal antibody labeled only the granular layers (Fig 3B,C,E,F,H localind to the cell periphef)·. COrT1!sponding to the dC!veloping CEo We noted during the COUtR of this srudy that the t .. ining pattent with the H.C! antibody w.u reminiscent ofehe localization of lonenn in the epidermi 113.141. By single and double immunofluorescence. however. it was c1c:lr tha t although there W:IIS significant co-localization of tilCSC two cpitopes (Fig l G-I) . mlllly sectiom reveal d that tbe B.Ct epilope wu expre~d sbortl) before loricrin (Fig 31) . evertheless. these imagc1 suggest localization of an antigen similar to that of the lorieno amino-terminus.
T b e Epllope of the B .C I Antibody C a n be Blocked by Synthetic P e ptide. To understand why our new TGase1 anli- Howcvcr. neither of these recombinant TGasel proreins significa ntly interfered with staining by the B.C ! an tibod y ( Fig 4B) . Second, from the results of Fi g 38 .B.H . synthetic pep tides were prepared from the known sequences of scvcrallikely CE TGase substrate proteins. including lori crio tenninal peptide sequences. a repeating sequen ce of involucrin. corresponding to known cross-linking peptide sequen ce sitcs [14.391. as well as membe rs of tbe SPR class of proteins. It is interesting that each of these possess remarkably conse rved sequences [9J. Although DO direct biochcmical proof exists yer, this sequence homo logy implies thai' these Iysille-and glutam in e-rich sequences may all be involved in cross-linking I"eactions [91 , because the similar sequences on the loricrin carbox y-temlinus contain known cross-linking sites [14] . We found that the SPIU ammo-tenninal peptide completely abo lished sraining of the H.C I antibody (Fi g 4D). whereas rhe amino-renninal SPR 1 (Fi g 4C). SPR3 ( Fig 4E) . and SPlU repeating peptides ( Fig 4H) T h e Major Epitope of the B. C1 Antibody Re side s o n th e SPRl Prote in To confi rm that the major epitope of the H.C! antibod y in fact resides on the SPit proteins. we chamcterized further lhe nature of the pl"oteins seen in F ig 2e. la"e 3 thar were in11l1unoprecipitated b y dle B.C I an tibody. The cycosoli c and membrane fractions of HaCaT keratinocytes were prepared essentially as described previously [211 for squamous cell carcinoma cells to generacc the antigen used in the manufactul"e of the B.C 1 antibody. However, we next solubilized m, e membrane fraction with a non-ionic detergent (octyl-IJ-glucopyranoside). and the rcsulting soluble and insolubl e components ( Fig SA. lanes 2 alld 3. respectively) were rhen immunoprecipitated with the B.C I antibody (Fig 58 . lalles 5 mId 6) . Two prominent bands of about 18 and 10 kOa were idencified (Fi g SC). These are the same as the middle and lowe r bands seen in Fig 2C. lalle 3 and F ig SA. I(lII t 2. By amino acid analysis ( Table I) . these two bands are chemically very similar to the SPR proteins I and 2. respectively. which arc also exp ressed abundantly in the epidemlis and in cultured kerarinocytcs [7.10. 11 1. This was cxplored fu rther by d irect amino acid scquencing for 10 cycles. These bands displayed 90% and t 00% o f sequence identity to dle amino temlini of tile human SI'R 1 and SPR2 protcins. respectively (Table 0) .
[n combination , th ese data therefore suggcSt that the majo r cpitope o f the B.C t antibod y resides o n me SPR2 protein expresscd in the epidennis and in othe.r strdcificd squanlous epithelia.
C oncluding R emarks The S .C I monoclonal antibody was eli cited against an insoluble membrane fraction obtained from sq uamou s cell ca rcinoma-13 cell s grown in culwl"c that had been treated with 12-0-tetradec:moyl-phorbol-13-acetare r21] . T his fraction retained TGase activity [2 11 . but the exact enzyme present was no t con finned. of :uui-TGase 1 activity as evidenced by Westero blotting experimenrs 12IJ, our inununologic and protein chemistty dara describt..-d here establish that the major epitopc of several batches of the conunc.rcially available fo nn oC the antibody resides on the SPR proteins.
Our new data establish that TGase I is expressed throughout normal human cpidennis (Fig 2) . Thus. our data show that TGasel prOl'cin appears coincident with its mRNA [23.24], and indicate thar 3 proposcd complex mechanism of rcgu lation of TGase 1 expression by thc prccranslational contro l of its mRNA 123-25} is no lo nger necessary. Funher studics will now be necessary to determine t.he function and substrate specificity of the TGasel enzyme during tcmlinal diEcrcnoatio n in the epidermis and in other nnltified squamous epithelia . 
